Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans
Fabienne Benz,Sarah Camara-Wilpert,Jakob Russel,Katharina G. Wandera,Rimvydė Čepaitė,Manuel Ares-Arroyo,José Vicente Gomes-Filho,Frank Englert,Johannes A. Kuehn,Silvana Gloor,Mario Rodríguez Mestre,Aline Cuénod,Mònica Aguilà-Sans,Lorrie Maccario,Adrian Egli,Lennart Randau,Patrick Pausch,Eduardo P.C. Rocha,Chase L. Beisel,Jonas Stenløkke Madsen,David Bikard,Alex R. Hall,Søren Johannes Sørensen,Rafael Pinilla-Redondo
DOI: https://doi.org/10.1016/j.chom.2024.04.016
IF: 31.316
2024-06-12
Cell Host & Microbe
Abstract:Benz and Camara-Wilpert et al. reveal that plasmid-encoded type IV-A3 CRISPR-Cas systems rely on host I-E adaptation machinery to acquire spacers and mediate inter-plasmid competition via DinG helicase-assisted transcriptional interference. By repurposing type IV-A3 as a programmable tool, clinical strains can be re-sensitized to antibiotics, offering promising approaches to tackle antibiotic resistance.
microbiology,virology,parasitology